Therefore, to investigate IGF1R as a mediator of IGF2 survival signaling, and as an potential therapeutic target in MRT, we determined whether blocking IGF1R inhibited tumor cell growth in vitro [30]. The gene discussed is IGF2; the disease is neoplasm.